Spero Therapeutics (SPRO) Other Working Capital Changes (2016 - 2026)
Spero Therapeutics posted quarterly Other Working Capital Changes of -$421000.0 for Q1 2026, down 24.93% year-on-year from -$560778.7 in Q1 2025, and up 69.71% on a QoQ basis from -$1.4 million in Q4 2025.
Spero Therapeutics (SPRO) has 11 years of Other Working Capital Changes data on file, last reported at -$421000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 24.93% year-over-year to -$421000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (up 3.13% YoY), and the FY2025 full-year result was -$1.4 million, down 12.52% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$421000.0, up from -$1.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.4 million in Q3 2022 and bottomed at -$3.6 million in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$324000.0 (2023), against an average of -$247941.2.
- The widest annual swing landed in 2024, when Other Working Capital Changes surged 263.89%; it then slumped 587.76% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$3.6 million in 2022, then soared by 91.93% to -$288000.0 in 2023, then tumbled by 306.94% to -$1.2 million in 2024, then retreated by 18.6% to -$1.4 million in 2025, then surged by 69.71% to -$421000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$421000.0 (Q1 2026), -$1.4 million (Q4 2025), and -$12000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -421,000.00 |
| Mar 31, 2026 | -421,000.00 |
| Dec 31, 2025 | -1.39 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | 337,000.00 |
| Jun 30, 2025 | 337,000.00 |
| Mar 31, 2025 | -337,000.00 |
| Mar 31, 2025 | -337,000.00 |
| Dec 31, 2024 | -1.17 Mn |
| Dec 31, 2024 | -1.17 Mn |
| Sep 30, 2024 | 531,000.00 |
| Sep 30, 2024 | 531,000.00 |
| Jun 30, 2024 | -556,000.00 |
| Jun 30, 2024 | -556,000.00 |
| Mar 31, 2024 | -49,000.00 |
| Mar 31, 2024 | -49,000.00 |
| Dec 31, 2023 | -288,000.00 |
| Dec 31, 2023 | -288,000.00 |
| Sep 30, 2023 | -324,000.00 |
| Sep 30, 2023 | -324,000.00 |
| Jun 30, 2023 | -656,000.00 |
| Jun 30, 2023 | -656,000.00 |
| Mar 31, 2023 | 164,000.00 |
| Mar 31, 2023 | 164,000.00 |
| Dec 31, 2022 | -3.57 Mn |
| Dec 31, 2022 | -3.57 Mn |
| Sep 30, 2022 | 4.43 Mn |
| Sep 30, 2022 | 4.43 Mn |
| Jun 30, 2022 | -620,000.00 |
| Jun 30, 2022 | -620,000.00 |
| Mar 31, 2022 | -285,000.00 |
| Mar 31, 2022 | -285,000.00 |
| Dec 31, 2021 | 3.08 Mn |
| Dec 31, 2021 | 3.08 Mn |
| Sep 30, 2021 | -2.74 Mn |
| Sep 30, 2021 | -2.74 Mn |
| Jun 30, 2021 | 176,000.00 |
| Jun 30, 2021 | 176,000.00 |
| Mar 31, 2021 | -195,000.00 |
| Mar 31, 2021 | -195,000.00 |
| Dec 31, 2020 | -9,000.00 |
| Dec 31, 2020 | -9,000.00 |
| Sep 30, 2020 | -77,000.00 |
| Sep 30, 2020 | -77,000.00 |
| Jun 30, 2020 | 106,000.00 |
| Jun 30, 2020 | 106,000.00 |
| Mar 31, 2020 | -92,000.00 |
| Mar 31, 2020 | -92,000.00 |
| Dec 31, 2019 | 6.71 Mn |
| Dec 31, 2019 | 6.71 Mn |
| Sep 30, 2019 | -4.55 Mn |
| Sep 30, 2019 | -4.55 Mn |
| Jun 30, 2019 | 297,000.00 |
| Jun 30, 2019 | 297,000.00 |
| Mar 31, 2019 | 448,000.00 |
| Mar 31, 2019 | 448,000.00 |
| Dec 31, 2018 | 6.20 Mn |
| Dec 31, 2018 | 6.20 Mn |
| Sep 30, 2018 | -109,000.00 |
| Sep 30, 2018 | -109,000.00 |
| Jun 30, 2018 | 7,000.00 |
| Jun 30, 2018 | 7,000.00 |
| Mar 31, 2018 | -604,000.00 |
| Mar 31, 2018 | -604,000.00 |
| Dec 31, 2017 | 779,000.00 |
| Dec 31, 2017 | 779,000.00 |
| Sep 30, 2017 | 101,000.00 |
| Sep 30, 2017 | 101,000.00 |
| Jun 30, 2017 | -770,000.00 |
| Jun 30, 2017 | -770,000.00 |
| Mar 31, 2017 | 465,000.00 |
| Mar 31, 2017 | 465,000.00 |
| Dec 31, 2016 | -1.69 Mn |
| Dec 31, 2016 | -1.69 Mn |